Corrigendum to: Identifying predictors of ventral hernia recurrence: systematic review and meta-analysis

Parker, Samuel G.; Mallett, Susan; Quinn, Laura; Wood, Christopher P.; Boulton, Richard; Jamshaid, Shiraz; Erotocritou, Marios; Gowda, Siri; Collier, William; Plumb, Andrew; Windsor, Alastair; Archer, Lucinda; Halligan, Steve

doi:10.1093/bjsopen/zrab047

Cited by 7 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…All patients with a ventral hernia since October 2018 who were [ 1 ] treated via either two or three bilateral BTA injections prior to abdominal wall reconstruction and [ 2 ] with availability of CT imaging before BTA treatment and 4–6 weeks after BTA were eligible for inclusion. Patients who were treated with another dosage (other than 600 units), volume (other than 120 mL) or selective muscle injections (other than all three muscle layers) were excluded.…”

Section: Methodsmentioning

confidence: 99%

“…Preferably, the abdominal wall defect is completely closed with native tissue and a mesh is used to reinforce the repair. A bridged repair—in which the defect is not completely closed with native tissue but bridged with mesh - is associated with a high risk of hernia recurrence and should be avoided [ 1 ]. In patients with a large hernia defect or with a large amount of peritoneal content residing outside the abdominal cavity (loss of domain), it may be difficult or even impossible to close the abdomen without the use of additional strategies.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Comparison of Two Versus Three Bilateral Botulinum Toxin Injections Prior to Abdominal Wall Reconstruction

Timmer¹,

Ibrahim²,

Claessen³

et al. 2023

J. Abdom. Wall Surg.

View full text Add to dashboard Cite

Background: Intramuscular injection of botulinum toxin A (BTA) induces a temporary muscle paralysis. In patients with a ventral hernia, preoperative injection of BTA in the muscles of the lateral abdominal wall (LAW) leads to thinning and lengthening of these muscles, making fascial closure more likely. In many hernia centres, treatment with BTA prior to abdominal wall reconstruction has therefore become standard care. However, evidence on the optimal BTA strategy is lacking.Methods: In this single-centre retrospective study, we analysed a consecutive cohort of ventral hernia patients that underwent bilateral BTA injections prior to abdominal wall reconstruction with available CT before and after BTA. We only included patients that were treated with exactly 600 units of Dysport®, diluted into 120 mL of saline, via either two- or three injections on each side into all three LAW muscle layers. The primary outcome was the change in LAW muscle length and thickness, comparing CT measures from before BTA and 4–6 weeks after the injections.Results: We analysed 67 patients; 30 had received two injections bilaterally and 37 had received three injections bilaterally. Baseline data showed no significant differences in LAW muscle thickness or length between groups. In both groups, the median LAW muscle thickness decreased with 0.5 cm (p < 0.001). The LAW muscle length increased with 0.9 cm (p = 0.001) and 1.2 cm (p < 0.001) in the two- and three bilateral injection group, respectively. The BTA-induced changes in LAW thickness and length were not significantly different between both groups (p = 0.809 and p = 0.654, respectively).Discussion: When using the exact same dosage and distribution volume of BTA in patients with a complex abdominal wall defect, two injections bilaterally in the lateral abdominal wall muscles are as effective as three injections bilaterally.

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Comparison of Two Versus Three Bilateral Botulinum Toxin Injections Prior to Abdominal Wall Reconstruction

Timmer¹,

Ibrahim²,

Claessen³

et al. 2023

J. Abdom. Wall Surg.

View full text Add to dashboard Cite

show abstract

S041—Trends and short-term outcomes of three approaches to minimally invasive repair of small ventral hernias. An ACHQC analysis

et al. 2022

View full text Add to dashboard Cite

Laparoscopic ventral and incisional hernia repair using intraperitoneal onlay mesh with peritoneal bridging

Ali

Sandblom

Wikner

et al. 2021

Hernia

View full text Add to dashboard Cite

Purpose The aim of this study was to assess the feasibility and safety of a novel IPOM procedure with peritoneal bridging (IPOM-pb) for laparoscopic ventral hernia repair, and to compare the outcomes of this procedure with IPOM with- (IPOM-plus) and IPOM without (sIPOM) defect closure. Method A single-centre retrospective study comparing a novel IPOM technique with peritoneal bridging (IPOM-pb) with the two commonly used IPOM techniques, IPOM with defect closure (IPOM-plus) and without defect closure (sIPOM). The intraoperative and postoperative data of patients who underwent laparoscopic IPOM ventral hernia repair were reviewed. Preoperative data, recurrence, and postoperative seroma, surgical site infection, and pain, were compared. Results From January 2017 to June 2020, a total of 213 patients underwent laparoscopic ventral and incisional hernia repair with IPOM technique. The mean length and width of the ventral hernia was 4.4 ± 1.8 cm and 3.6 ± 1.4 cm, respectively, and the mean BMI was 30.1 ± 5.2 kg/m2. The mean operating time was 67 ± 28 min and was longer for IPOM-pb (71 ± 27 min), less for IPOM-plus (63 ± 28 min), and least for sIPOM (61 ± 26 min). The incidence of early postoperative seroma was least in IPOM-pb (1/98, 1%), and similar in the IPOM-plus (4/94, 4%) and sIPOM (1/21, 5%) group. Late postoperative seroma was found only in IPOM-plus (2, 2%). The incidence of early and late postoperative pain was relatively higher in sIPOM (3, 14%; 1, 5%, respectively) compared to IPOM-pb and IPOM-plus in the early (5, 5% and 6, 6%) and late (2, 2% and 1, 1%) postoperative period, respectively. Surgical site infection was higher in sIPOM group (3, 14%), compared to IPOM-pb (1, 1%), and IPOM-plus (3, 3%). Recurrence rates were similar in IPOM-pb group (3/98, 3%) and IPOM-plus (3/94, 3%), and none in sIPOM (0/21). Conclusion IPOM with peritoneal bridging is as feasible and safe as conventional IPOM with defect closure and simple non-defect closure. However, a large randomised controlled trial is required to confirm this finding.

show abstract

Corrigendum to: Identifying predictors of ventral hernia recurrence: systematic review and meta-analysis

Cited by 7 publications

References 0 publications

Comparison of Two Versus Three Bilateral Botulinum Toxin Injections Prior to Abdominal Wall Reconstruction

Comparison of Two Versus Three Bilateral Botulinum Toxin Injections Prior to Abdominal Wall Reconstruction

S041—Trends and short-term outcomes of three approaches to minimally invasive repair of small ventral hernias. An ACHQC analysis

Laparoscopic ventral and incisional hernia repair using intraperitoneal onlay mesh with peritoneal bridging

Contact Info

Product

Resources

About